Medication reviews in older adults

Abstract

Increased scrutiny of medication regimens by healthcare professionals across the continuum of care is to be expected as the worldwide population ages. Similarly, pharmaceutical companies will be expected to develop new drugs that are safe and effective for older adults, including those who are frail, have complex comorbidities, and/or are prescribed multiple medications. Understanding the medication review process from the clinician perspective can help pharmaceutical industry professionals involved in drug development for older adults anticipate potential post-marketing pitfalls.